Navigation Links
Brittlestar provides new model for stem cell research

Scientists at the Royal Swedish Academy of Sciences Kristineberg Marine Research Station are using the brittlestar as a new model for studying stem cells, allowing them to do experiments that avoid the ethical issues associated with human and vertebrate research.

The brittlestar, Amphiura filiformis, is a close relative of the starfish and can regenerate lost arms in a matter of weeks. Sam Dupont and Mike Thorndyke are presenting their latest work on Friday 7th April at the Annual Meeting for the Society for Experimental Biology [session A8].

"What is really amazing is that the nervous system starts to be functional only a few days after the beginning of regeneration", says Dr Sam Dupont, "It is a more realistic model for stem cell biology because we can study the cells in the living organism, not just in culture in the lab."

The researchers are particularly interested in studying the recovery of the nervous system which could have possible applications in the future for understanding and treating neurodegenerative diseases. Using the brittlestar as a model is particularly useful as it is more closely related to vertebrates than previous models with extensive regeneration capabilities such as Hydra.


'"/>

Source:Society for Experimental Biology


Page: 1

Related biology news :

1. MetaChip provides quick, efficient toxicity screening of potential drugs
2. NYU and MSKCC research provides model for understanding chemically induced cancer initiation
3. Nature provides inspiration for important new adhesive
4. New plant DNA libraries provides massive boost to worlds plant researchers
5. NASA satellite data provides rapid analysis of Amazon deforestation
6. Study provides insight into cellular defenses against genetic mutation
7. Customized gene chip provides rapid detection of genetic changes in childrens cancer
8. Vaccine provides 100 percent protection against avian flu virus in animal study
9. New hybrid virus provides targeted molecular imaging of cancer
10. Ancient DNA provides clues to the evolution of social behavior
11. Use of amino acid supplement following a heart attack provides no benefit, may be harmful
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... April 24, 2017 Janice Kephart ... with  Identity Strategy Partners, LLP (IdSP) , today ... without President Trump,s March 6, 2017 Executive ... , refugee vetting can be instilled with greater confidence, ... now, all refugee applications are suspended by until ...
(Date:4/13/2017)... PUNE, India , April 13, 2017 According ... Identity Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication ... by MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 ... Annual Growth Rate (CAGR) of 17.3%. ... ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... RPS ... clinical study that demonstrates the accuracy of the FebriDx® test, a commercially-ready, ... acute bacterial and viral respiratory tract infections by testing the body’s immune ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
Breaking Biology Technology: